[go: up one dir, main page]

Santos et al., 2015 - Google Patents

Functionalized chitosan derivatives as nonviral vectors: Physicochemical properties of acylated N, N, N-trimethyl chitosan/oligonucleotide nanopolyplexes

Santos et al., 2015

View PDF
Document ID
8114621451993785747
Author
Santos J
Moreno P
Mansur A
Leiro V
Mansur H
Pêgo A
Publication year
Publication venue
Soft matter

External Links

Snippet

Cationic polymers have recently attracted attention due to their proven potential for nonviral gene delivery. In this study, we report novel biocompatible nanocomplexes produced using chemically functionalized N, N, N-trimethyl chitosan (TMC) with different N-acyl chain …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A61K47/48884—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A61K47/48892—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
    • A61K47/489—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the material constituting the nanoparticle being a polymer obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone, polyvinylalcohol

Similar Documents

Publication Publication Date Title
Santos et al. Functionalized chitosan derivatives as nonviral vectors: Physicochemical properties of acylated N, N, N-trimethyl chitosan/oligonucleotide nanopolyplexes
Muddineti et al. Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells
Amar-Lewis et al. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing
Raemdonck et al. Biodegradable dextran nanogels for RNA interference: focusing on endosomal escape and intracellular siRNA delivery
Ayatollahi et al. Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells
Juneja et al. Combination of nucleic acid and mesoporous silica nanoparticles: optimization and therapeutic performance in vitro
Mobarakeh et al. Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle
US10058620B2 (en) Dextran-peptide hybrid for efficient gene delivery
Choi et al. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes
Guţoaia et al. Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity
Yao et al. Amphoteric hyaluronic acid derivative for targeting gene delivery
Kamra et al. New water-soluble oxyamino chitosans as biocompatible vectors for efficacious anticancer therapy via co-delivery of gene and drug
Layek et al. Caproic acid grafted chitosan cationic nanocomplexes for enhanced gene delivery: effect of degree of substitution
Darvishi et al. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells
Xiao et al. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages
Tripathi et al. Depolymerized chitosans functionalized with bPEI as carriers of nucleic acids and tuftsin-tethered conjugate for macrophage targeting
Lee et al. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles
Moraes et al. Synthesis of cationic quaternized pullulan derivatives for miRNA delivery
Pengnam et al. A novel plier-like gemini cationic niosome for nucleic acid delivery
Bae et al. Intracellular delivery of heparin complexed with chitosan-g-poly (ethylene glycol) for inducing apoptosis
Liu et al. A novel gene carrier prepared from triple helical β-glucan and polydeoxyadenylic acid
Sajomsang et al. Effects of molecular weight and pyridinium moiety on water-soluble chitosan derivatives for mediated gene delivery
Sardo et al. Improvements in rational design strategies of inulin derivative polycation for siRNA delivery
Moreno et al. Delivery of splice switching oligonucleotides by amphiphilic chitosan-based nanoparticles
Meng et al. A spermine conjugated stearic acid-g-chitosan oligosaccharide polymer with different types of amino groups for efficient p53 gene therapy